Population shift in antibody immunity following the emergence of a SARS-CoV-2 variant of concern.

Journal: Scientific reports

Volume: 15

Issue: 1

Year of Publication: 2025

Affiliated Institutions:  SAMRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa. jinalb@nicd.ac.za. SAMRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa. National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa. Human Sciences Research Council, Pretoria, South Africa. SAMRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa. pennym@nicd.ac.za.

Abstract summary 

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) exhibit escape from pre-existing immunity and elicit variant-specific immune responses. In South Africa, the second wave of SARS-CoV-2 infections was driven by the Beta VOC, which coincided with the country-wide National COVID-19 Antibody Survey (NCAS). The NCAS was conducted between November 2020 and February 2021 to understand the burden of SARS-CoV-2 infection through seroprevalence. We evaluated 649 NCAS sera for spike binding and pseudovirus neutralizing antibodies. We classified individuals as ancestral or D614G neutralizers (114/649), Beta neutralizers (96/649), double neutralizers (375/649) or non-neutralizers (62/649). We observed a consistent decrease in preferential neutralization against the D614G variant from 68 to 18% of individuals over the four sampling months. Concurrently, samples with equivalent neutralization of both variants, or with enhanced neutralization of the Beta variant, increased from 32 to 82% of samples. Neutralization data showed that geometric mean titers (GMTs) against D614G dropped 2.4-fold, while GMTs against Beta increased 2-fold during this same period. A shift in population humoral immunity in favor of Beta-directed or cross-neutralizing antibody responses, paralleled the increase in genomic frequency of the Beta variant in South Africa. Understanding similar population immunity shifts could elucidate immunity gaps that drive SARS-CoV-2 evolution.

Authors & Co-authors:  Bhiman Jinal N JN Madzorera Vimbai Sharon VS Mkhize Qiniso Q Scheepers Cathrine C Hermanus Tandile T Ayres Frances F Makhado Zanele Z Moyo-Gwete Thandeka T Crowther Carol C Singh Beverley B Fortuin Mirriam M Marinda Edmore E Jooste Sean S Zuma Khangelani K Zungu Nompumelelo N Morris Lynn L Puren Adrian A Simbayi Leickness L Moyo Sizulu S Moore Penny L PL

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Tegally, H. et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature592, 438–443. 10.1038/s41586-021-03402-9 (2021).
Authors :  20
Identifiers
Doi : 5549
SSN : 2045-2322
Study Population
Male,Female
Mesh Terms
Humans
Other Terms
Antibody immunity;Beta variant;Neutralizing antibodies;Population shift;SARS-CoV-2;South Africa
Study Design
Study Approach
Country of Study
South Africa
Publication Country
England